Cargando…
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial
BACKGROUND: The risk of death from spontaneous intracerebral haemorrhage is increased for people taking antiplatelet drugs. We aimed to assess the feasibility of randomising patients on antiplatelet drug therapy with spontaneous intracerebral haemorrhage to desmopressin or placebo to reduce the anti...
Autores principales: | Desborough, Michael J R, Al-Shahi Salman, Rustam, Stanworth, Simon J, Havard, Diane, Woodhouse, Lisa J, Craig, Jennifer, Krishnan, Kailash, Brennan, Paul M, Dineen, Robert A, Coats, Tim J, Hepburn, Trish, Bath, Philip M, Sprigg, Nikola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284719/ https://www.ncbi.nlm.nih.gov/pubmed/37353276 http://dx.doi.org/10.1016/S1474-4422(23)00157-6 |
Ejemplares similares
-
Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial
por: Desborough, Michael J R, et al.
Publicado: (2020) -
Outcomes in Antiplatelet‐Associated Intracerebral Hemorrhage in the TICH‐2 Randomized Controlled Trial
por: Law, Zhe Kang, et al.
Publicado: (2021) -
Measures of intracranial compartments in acute intracerebral haemorrhage: data from the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke-2 Trial (RIGHT-2)
por: Krishnan, Kailash, et al.
Publicado: (2022) -
Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trial
por: Appleton, Jason Philip, et al.
Publicado: (2023) -
Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial
por: Dineen, Rob A, et al.
Publicado: (2018)